ROSEMARIE SCHMANDT to Antibodies, Monoclonal
This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about Antibodies, Monoclonal.
Connection Strength
0.047
-
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. J Natl Cancer Inst. 2006 Nov 01; 98(21):1558-70.
Score: 0.029
-
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biol Ther. 2010 Feb; 9(3):176-82.
Score: 0.009
-
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. J Natl Cancer Inst. 2009 Sep 02; 101(17):1193-205.
Score: 0.009